Hot Stocks

The stock market changes from minute to minute, and what’s hot today may not be hot tomorrow. Our expert analysts spot hot stocks that are heating up before the crowd swoops in to bid prices higher, and our journalists sift through the noise to shine a light on trending investments -- in spaces ranging from quantum computing to marijuana stocks -- to determine whether they’re actually worth your time.

Roblox’s Network Effects Puts It Into a Field of Its Own

By Thomas Logue, CFA
Roblox's incredible network effects, robust user growth and the digital era make RBLX stock a prime candidate for long-term success.

Earnings Could Help Ideanomics Stock Recapture Investor Confidence

By Louis Navellier and the InvestorPlace Research Staff
IDEX stock has been faltering ever since the company announced it would no longer report monthly MEG unit delivery numbers.

Buy Snap Stock as the ‘Great Reopening’ Catalyst Begins

By Luke Lango, InvestorPlace Senior Investment Analyst
As more people travel, party, and socialize more in 2021/22, they're going to want to share those experiences more on Snapchat, so buy SNAP stock.

Avoid Sundial Stock As It’s Running on Reddit Hype

By InvestorPlace Research Staff
SNDL stock had a nice pop earlier this year, but the rally has been unsustainable since. We're avoiding Sundial for now in favor of others.

Aphria Stock Still Has Potential For Patient Investors

By Louis Navellier and the InvestorPlace Research Staff
Marijuana legalization won't happen as quickly as APHA stock investors had hoped. But all signs are pointing toward the eventuality.

Zomedica is a Bet Worth Taking That Makes Sense

By Alex Sirois, InvestorPlace Contributor
ZOM stock is simply too good of an opportunity to pass by. Veterinary diagnostics is a growing sector, and ZOM revenues are just beginning.

Why I’m Still Saying No to Nokia

By Joanna Makris, Head of Equity Research, Boardroom Alpha
NOK stock is a long-term play on 5G, but with O-RAN and FPGA issues, Nokia will likely see more downside ahead. Wait before you buy.

There’s No Need to Chase Bubbly Bionano Genomics Stock

By InvestorPlace Research Staff
A single study launched an epic rally in BNGO stock. But the company still has much to prove, and 3,400% gains don't price in the risks.

An Automaker Just Soared Over 50% in a Month – and It Wasn’t Tesla

By Eric Fry, Editor, Fry's Investment Report
When it comes to the EV and battery sector, you likely wouldn't consider this automaker. However, they are a major player in the space.

7 Meme Stocks to Buy After the Roblox IPO

By Chris Markoch, InvestorPlace Contributor
More stimulus means more money flowing into the stock market. Here are seven meme stocks that may benefit from the government’s largesse.

Why PSTH Is the Poster Child of SPAC Hysteria

By Chris MacDonald, InvestorPlace Contributor
Investors in PSTH stock have seen impressive gains in lieu of any annoucnement thus far, but is it worth getting into this stock today?

Place Your Bets on DraftKings Stock Because It Is Going Places

By Nicolas Chahine, InvestorPlace Contributor
DKNG stock has done well under tough economic conditions. The stimulus and the pandemic gave it a shot of adrenaline.

BioNano Genomics Is About the Future, Not the Present

By Chris Markoch, InvestorPlace Contributor
BioNano may cause great disruption in the field of genetics. However, the payoff for investing in BNGO stock is likely to be years away.

Iterum Therapeutics Stock Looks Like a High-Risk Name Here

By Larry Ramer, InvestorPlace Contributor
The fact that other antibiotic makers have declared bankruptcy in recent years is a negative sign for Iterum. Long-term investors should avoid ITRM stock.

Apex Technology Acquisition Looks Pricey, but May Be Attractive Post Merger

By Chris MacDonald, InvestorPlace Contributor
As far as SPACs go, APXT stock certainly piques my interest as an interesting growth option in the booming SPAC rush today.

Strong Sales, Deliveries Create Solid Value Case for XPeng Stock

By Mark R. Hake, CFA
XPeng sales and deliveries are strong and XPEV stock is good value. XPEV stock is worth at least $57, or 48% above today’s price, based on comps.

Infused Beverages Pour on the Potential Gains for Aphria Stock Investors

By Will Ashworth, InvestorPlace Contributor
Aphria CEO Irwin Simon continues to like cannabis-infused drinks, which makes APHA stock one of the top global cannabis plays you can make.

7 Overvalued Stocks Still Worth Your Money

By Faisal Humayun, InvestorPlace Contributor
Here are seven overvalued stocks that still seem attractive considering the business growth potential. These overvalued stocks might still have fuel in the tank to rally.

Why Romeo Power Is the Quintessential Post-SPAC Stock

By Vince Martin, InvestorPlace Contributor
The SPAC trend has made early-stage plays like RMO stock available to investors. That's been a double-edged sword.
Load More Articles